Risdiplam Gets Prority Review for Presymptomatic Spinal Muscular Atrophy By Brian Park, PharmD Publish Date January 25, 2022
FDA Restricts Use of 2 Monoclonal Antibody Therapies Due to Omicron Variant By Brian Park, PharmD Publish Date January 25, 2022
Medtronic’s SCS Therapy Approved for Painful Diabetic Peripheral Neuropathy By Steve Duffy Publish Date January 25, 2022
Nucala 40mg Prefilled Syringe Approved for Children With Severe Eosinophilic Asthma By Brian Park, PharmD Publish Date January 25, 2022
FDA Clears PICO Systems for Closed Surgical Incisions to Reduce Wound Complications By Brian Park, PharmD Publish Date January 25, 2022
Adding Immunotherapy to Chemo Ups Survival in Advanced Biliary Tract Cancer Publish Date January 25, 2022
Purified Cortrophin Gel Now Available for Certain Chronic Autoimmune Disorders By Brian Park, PharmD Publish Date January 24, 2022
FDA Denies Approval of Long-Acting Pediatric Growth Hormone Therapy By Brian Park, PharmD Publish Date January 24, 2022
Skyrizi Gets FDA Approval for Psoriatic Arthritis By Brian Park, PharmD Publish Date January 24, 2022
FDA Greenlights Use of Veklury for Outpatient COVID-19 Treatment By Diana Ernst, RPh Publish Date January 24, 2022
Oncopeptides Reconsiders Pepaxto Withdrawal Following Data Review By Diana Ernst, RPh Publish Date January 24, 2022
Peanut Oral Immunotherapy at Younger Age Ups Desensitization in Children Publish Date January 24, 2022
